On April 9, 2024, CancerIQ’s Founder and CEO Feyi Ayodele was named as one of Modern Healthcare’s Top Innovators of 2024. The list acknowledges innovators that are improving quality and access to care, as well as constantly striving to improve the clinical and financial results of their companies.
“I’m honored to receive this incredible recognition from Modern Healthcare,” said Feyi Ayodele in a press release on Tuesday. “I want to thank our team, investors, partners, and most importantly, our customers for believing in me and for propelling CancerIQ to be the best, most innovative solution in its class.”
Modern Healthcare’s Editor-in-Chief Mary Ellen Podmolik gave further context for the recipients of this year’s Top Innovators award, stating, “The role of innovation has always been paramount in healthcare, and our 2024 honorees as top Innovators are driving real change in the industry.” She goes on to say, “The wide variety of projects underway by these executives and organizations demonstrates a dedication to tackling the ‘what ifs’ that can improve the delivery of healthcare and improve communities and the patient experience.”
Founded in 2013 by Feyi Olopade Ayodele, MBA, and her mother, Olufunmilayo (Funmi) Olopade, MD, CancerIQ has spent over a decade working to establish itself as one of the foremost authorities in cancer detection, using genetic information to predict the risk factor for patients, as well as to more accurately identify the most effective course of treatment for individual cancer cases. The company also works with healthcare providers to organize oncology workflows, improve task automation, and streamline genetic counseling and cancer testing, and much more.
Read the full press release here.
See related materials: